MACUSTAR | Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076
01-09-2017
-31-05-2024
Show more information
Organisation
CARL ZEISS MEDITEC AG